Ferrosobin G Syrup 300 mg/5 ml is a form of iron commonly used to treat or prevent iron deficiency anemia. Iron is an essential mineral required for producing hemoglobin, the protein in red blood cells responsible for oxygen transport. Ferrosobin G Syrup 300 mg/5 ml is often prescribed when dietary intake is insufficient or when the body has increased iron requirements, such as during pregnancy or chronic blood loss.
Ferrosobin G Syrup 300 mg/5 ml is used for:
| Brand Name | Ferrosobin G |
|---|---|
| Type | Syrup |
| Weight | 300 mg/5 ml |
| Generic | Ferrous Gluconate |
| Manufacturer | Seema Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Ferrosobin G Syrup 300 mg/5 ml replenishes iron stores in the body, facilitating the production of hemoglobin in red blood cells. Once absorbed, iron is incorporated into hemoglobin, allowing the blood to effectively carry oxygen from the lungs to tissues. Iron is also essential for myoglobin production in muscles and for various enzymatic processes.
It may take 2-3 weeks for the initial effects of Ferrosobin G Syrup 300 mg/5 ml to be noticeable. Complete restoration of iron levels typically requires several months of therapy, depending on the severity of the deficiency and the patient’s adherence to treatment.
Ferrosobin G Syrup 300 mg/5 ml is absorbed primarily in the duodenum and jejunum of the small intestine. Its absorption can be enhanced by taking it with vitamin C or on an empty stomach. However, food may reduce gastrointestinal side effects like nausea and abdominal discomfort.
Iron from Ferrosobin G Syrup 300 mg/5 ml is primarily utilized in the production of hemoglobin and myoglobin. Excess iron is excreted via the gastrointestinal tract, and a minimal amount is excreted through urine and sweat.
The dosage of Ferrosobin G Syrup 300 mg/5 ml depends on the patient’s iron requirements:
Iron overdose, particularly in children, can be dangerous and potentially fatal. Symptoms of overdose include severe nausea, vomiting, diarrhea, abdominal pain, and in severe cases, cardiovascular collapse and liver failure. Immediate medical intervention is required in cases of suspected overdose.
Ferrosobin G Syrup 300 mg/5 ml is commonly prescribed during pregnancy to prevent iron deficiency anemia. It is considered safe for use in pregnancy, with a typical dose of around 30 mg of elemental iron per day to meet increased iron demands.
Iron from Ferrosobin G Syrup 300 mg/5 ml is not excreted in significant amounts in breast milk, and it is considered safe for use in breastfeeding women. Supplementation during lactation can help replenish iron stores, which may be depleted during pregnancy and breastfeeding.
An overdose of Ferrosobin G Syrup 300 mg/5 ml, especially in children, can be life-threatening. Symptoms of acute iron toxicity include nausea, vomiting, abdominal pain, lethargy, and in severe cases, shock, metabolic acidosis, and organ failure. Immediate medical attention is required, and treatment includes gastric lavage and iron chelation therapy.
Ferrosobin G Syrup 300 mg/5 ml is distributed widely throughout the body, with iron primarily being incorporated into hemoglobin in red blood cells, myoglobin in muscles, and stored in the liver, spleen, and bone marrow as ferritin or hemosiderin.
The half-life of iron depends on its incorporation into hemoglobin and other metabolic processes. Ferrosobin G Syrup 300 mg/5 ml is absorbed over a period of 4 to 6 hours, but the therapeutic effects may last much longer as iron is gradually utilized by the body.
Iron from Ferrosobin G Syrup 300 mg/5 ml is primarily cleared from the body via incorporation into hemoglobin, with excess amounts excreted in feces. Minimal iron is lost through urine and sweat.
See in details version Ferrosobin G Syrup 300 mg/5 ml also Ferrosobin G Syrup 300 mg/5 ml in bangla